Shares of Concentra Group (CON) have gained 2.9% over the past four weeks to close the last trading session at $22.03, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $28 indicates a potential upside of 27.1%.The average comprises eight short-term price targets ranging from a low of $25 to a high of $30, with a standard deviation of $1.85. While the lowest estimate indicates an ...

医疗行业表现分析 - 医疗行业包含999家公司 在Zacks行业排名中位列第5 [2] - 医疗行业股票今年平均回报率为-5.6% [4] - 医疗-生物医学和遗传学子行业包含506家公司 今年平均下跌6.5% [6] - 医疗服务子行业包含58家公司 今年下跌2.4% [6] Benitec Biopharma Limited (BNTC) - 公司Zacks评级为2级(买入) 反映盈利前景改善 [3] - 过去90天全年盈利预期上调61.8% [4] - 今年迄今回报率7.7% 显著跑赢医疗行业平均水平(-5.6%) [4] - 属于医疗-生物医学和遗传学子行业 该子行业今年平均下跌6.5% [6] Concentra Group (CON) - 公司Zacks评级为2级(买入) [5] - 过去3个月全年EPS预期上调4.5% [5] - 今年迄今回报率14.9% 跑赢医疗行业平均水平 [5] - 属于医疗服务业 该子行业今年下跌2.4% [6] 投资机会 - Benitec Biopharma和Concentra Group可能继续保持强劲表现 [7]

Concentra Group Holdings Parent (CON) 2025 Conference May 14, 2025 01:40 PM ET Speaker0 UNIDENTIFIED They are the largest occupational health therapy provider in The U. S. And today with us, we have Keith Newton, who's the CEO and Matt DiCanyo, who's the CFO. And I guess we decided to go right into Q and A, right? Sure. Since it feels like not everyone is up to speed on the story, I figured maybe we should just start with, like, just if there's anybody in the room, just in case, to levels that kind of walk ...

股价表现与目标价分析 - Concentra Group (CON) 最新收盘价为21 40美元 过去四周上涨5 5% 华尔街分析师给出的平均目标价为28美元 意味着30 8%的上行空间 [1] - 八位分析师的目标价区间为25至30美元 标准差为1 85美元 最低目标价隐含16 8%涨幅 最高目标价隐含40 2%涨幅 标准差反映分析师预测的一致性 [2] - 分析师目标价常因商业利益被高估 但低标准差表明对股价方向和幅度的共识较强 可作为研究起点 [8][9] 盈利预测与评级 - 分析师普遍上调CON的EPS预测 Zacks一致预期过去一个月增长1 5% 三份预测上调且无下调 [12] - CON目前获Zacks Rank 2(买入)评级 位列4000多只股票前20% 基于盈利预测相关四项因素 显示短期上行潜力 [13] 目标价的有效性争议 - 学术研究表明目标价常误导投资者 实际预测准确性较低 分析师虽掌握公司基本面 但目标价易受商业关系影响 [7][8] - 盈利预测修正趋势与股价走势强相关 比目标价更能预示上行潜力 但无法量化涨幅 [4][11]

Concentra Group Holdings Parent (CON) Q1 2025 Earnings Call May 08, 2025 09:00 AM ET Company Participants Keith Newton - CEOMatthew DiCanio - President & CFOBenjamin Rossi - Equity Research AssociateBen Hendrix - Vice PresidentEdward Kressler - Managing Director Conference Call Participants Jamie Perse - AnalystJoanna Gajuk - Equity Research AnalystStephen Baxter - Senior Equity Research AnalystJustin Bowers - Analyst Operator Good morning and thank you for joining us today for Concentra Group Holdings Pare ...

Concentra Group Holdings Parent (CON) Q1 2025 Earnings Call May 08, 2025 09:00 AM ET Speaker0 Good morning and thank you for joining us today for Concentra Group Holdings Parent Incorporated Earnings Conference Call to discuss the First Quarter twenty twenty five Results. Speaking today are the company's Chief Executive Officer, Keith Newton and the company's President and Chief Financial Officer, Matt Piccanio. Management will provide an overview and then open the call for questions. Before we get started, ...

©2025 Concentra Inc. All rights reserved. Disclaimer Forward-Looking Statements This presentation contains forward-looking statements that express the Company's current opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results that include, but are not limited to, financial guidance and other projections and forecasts. Forward looking statements include statements that are not historical facts and can be identified by terms such as "anticipate," ...

Concentra Group (CON) came out with quarterly earnings of $0.32 per share, beating the Zacks Consensus Estimate of $0.31 per share. This compares to earnings of $0.47 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.23%. A quarter ago, it was expected that this provider of occupational health services would post earnings of $0.16 per share when it actually produced earnings of $0.17, delivering a surprise of 6.25%.Over the la ...

For the transition period from to UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file numbers: 001-42188 CONCENTRA GROUP HOLDINGS PARENT, INC. (Exact name of Registrant as specified in its Charter) (State or Other Jurisdictio ...

"Concentra reported a solid start to 2025 with strong revenue and Adjusted EBITDA growth in the first quarter. With a deep understanding of patient and client needs and market dynamics, we continue to execute on key drivers of growth and deliver a comparative market advantage. Maintaining this focus ensures we continue to achieve our strategic business objectives for the year," said Keith Newton, Chief Executive Officer of Concentra. NEWS RELEASE FOR IMMEDIATE RELEASE Concentra Group Holdings Parent, Inc. A ...